FDG-PET/CT in the Evaluation of Patients With Suspected Cholecystitis
The Utility of FDG-PET and PET/CT in the Evaluation of Patients With Suspected Cholecystitis
Sponsor: Alan D. Waxman, M.D.
A NA clinical study on Cholecystitis, this trial is completed. The trial is conducted by Alan D. Waxman, M.D. and has accumulated 11 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Jan 2020 — Jan 2021 [monthly]
Completed NA
-
Nov 2019 — Jan 2020 [monthly]
Completed NA
-
Jun 2018 — Nov 2019 [monthly]
Completed NA
-
Aug 2017 — Jun 2018 [monthly]
Completed NA
-
Feb 2017 — Aug 2017 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Jul 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alan D. Waxman, M.D.
For direct contact, visit the study record on ClinicalTrials.gov .